Brokerage Expectations in Spotlight For Merit Medical Systems, Inc. (NASDAQ:MMSI), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

Brokerage firms currently have a positive stance on shares of Merit Medical Systems, Inc. (NASDAQ:MMSI). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.60. Those same analysts are projecting that the stock will reach $37.58 on a short term basis.

Performance
At the time of writing, the stock was trading at $37.00. This represents a change from most recent open price of -0.40%. In terms of performance, year to date, the stock is 36.23%. The monthly stock performance comes in at 9.06%. For the quarter, shares are performing at 14.42%. Weekly performance analysis shows the equity at 3.44%.

Technicals
In taking a look at technical levels, shares are trading 11.79% away from the 50 day simple moving average and 33.71% away from the 200 day simple moving average. Based on a recent bid, the stock is trading 0.00% away from it’s 52- week high and 103.07% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Merit Medical Systems, Inc.’s RSI stands at 70.84. In looking at volatility levels, the shares saw weekly volatility of 2.83% and 2.51% over the past month.

Equity Research firms currently have a positive stance on shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.20. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $83.47 on a short term basis.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares typically trade an average volume of 571.40 and institutions hold 99.00% of the total shares.  

MOVING AVERAGES

We see here that the stock is 13.13% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of 10.11% from current levels.  Further back, their 200-Day Simple Moving Average is -5.94% difference from today’s price.  Currently, the stock is -1.37% from its 50-Day High and 26.61% from the 50-day low. 

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)‘s stock has performed at -9.16%.  Breaking that down further, it has performed 16.61% for the week, 8.24% for the month, -24.92% over the last quarter, -11.71% for the past half-year and 16.15% for this last year. 

Leave a Comment